Raia Drogasil S.A. RADLY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.46% | 16.12% | 6.18% | -1.97% | -5.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.46% | 16.12% | 6.18% | -1.97% | -5.34% |
| Cost of Revenue | 21.94% | 15.36% | 5.71% | -2.39% | -5.85% |
| Gross Profit | 26.98% | 17.89% | 7.30% | -0.98% | -4.13% |
| SG&A Expenses | 24.15% | 15.78% | 7.15% | -0.12% | -3.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 969.96% | 1,056.35% | -662.69% | 69.67% | 81.68% |
| Total Operating Expenses | 23.17% | 16.09% | 5.99% | -1.68% | -5.06% |
| Operating Income | 27.99% | 16.49% | 9.04% | -6.36% | -9.49% |
| Income Before Tax | 28.15% | 4.61% | -5.01% | -11.78% | -13.70% |
| Income Tax Expenses | 81.72% | -16.16% | -24.78% | -70.00% | -55.29% |
| Earnings from Continuing Operations | 22.87% | 7.34% | -1.38% | 3.09% | -5.00% |
| Earnings from Discontinued Operations | -72.93% | 223.44% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 150.13% | 74.55% | 76.52% | 44.71% | 57.81% |
| Net Income | 18.51% | 11.83% | 5.82% | 11.04% | 3.37% |
| EBIT | 27.99% | 16.49% | 9.04% | -6.36% | -9.49% |
| EBITDA | 27.35% | 18.16% | 10.62% | -4.91% | -7.89% |
| EPS Basic | 21.88% | 31.11% | 23.03% | 28.36% | 20.85% |
| Normalized Basic EPS | 25.99% | 17.93% | 10.56% | -3.51% | -0.95% |
| EPS Diluted | 20.94% | 30.38% | 22.87% | 28.31% | 20.72% |
| Normalized Diluted EPS | 25.42% | 16.91% | 10.12% | -3.87% | -1.31% |
| Average Basic Shares Outstanding | -2.98% | -17.71% | -17.34% | -16.36% | -16.76% |
| Average Diluted Shares Outstanding | -2.30% | -16.74% | -16.96% | -16.04% | -16.38% |
| Dividend Per Share | -3.37% | 73.10% | 211.45% | -38.79% | 13.10% |
| Payout Ratio | 0.00% | 0.23% | 0.30% | -0.09% | -0.02% |